Wells Fargo & Company Alpha Tau Medical Ltd. Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding DRTS
# of Institutions
28Shares Held
1.35MCall Options Held
0Put Options Held
0-
Levin Capital Strategies, L.P. New York, NY307KShares$1.2 Million0.07% of portfolio
-
Hoyle Cohen, LLC269KShares$1.05 Million0.05% of portfolio
-
High Tower Advisors, LLC Chicago, IL231KShares$902,0520.0% of portfolio
-
ETF Managers Group, LLC Summit, NJ66.3KShares$259,3340.01% of portfolio
-
Satovsky Asset Management LLC53.6KShares$209,5990.03% of portfolio
About Alpha Tau Medical Ltd.
- Ticker DRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,011,296
- Market Cap $270M
- Description
- Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...